Reprogramming Macrophage Phenotypes With Photobiomodulation for Improved Inflammation Control in ENT Organ Tissues
Clinical and Experimental Otorhinolaryngology · 28.02.2025 · 18 (1) · 1-13
DOI: 10.21053/ceo.2024.00286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Otorhinolaryngology, erschienen am 28.02.2025. Verfasst von Ken Woo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ecology and Evolutionary Biology, University of California, Los Angeles, Los Angeles, CA, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Dankook Institute of Medicine & Optics, National Research Foundation of Korea, Ministry of Education.
Abstract (Originalsprache)
Photobiomodulation (PBM), a noninvasive phototherapy that utilizes wavelengths between red and near-infrared light, has emerged as a promising approach for controlling inflammation by modulating macrophage polarization. This review investigates the therapeutic potential of PBM in treating ENT-specific inflammatory conditions, such as chronic rhinosinusitis and otitis media, focusing on its effects on macrophage phenotypes and evidence from preclinical studies. By promoting mitochondrial activity, increasing adenosine triphosphate production, and modulating reactive oxygen species, PBM has been shown to shift macrophages from a pro-inflammatory to an anti-inflammatory phenotype. Studies have demonstrated that PBM enhances tissue repair, reduces inflammatory markers, and promotes wound healing. Moreover, PBM facilitates the polarization of M2 macrophages, a crucial factor in resolving mucosal inflammation in the nasal, pharyngeal, and middle ear cavities, as well as restoring tissue homeostasis. The anti-inflammatory effects of PBM are attributed to its ability to influence several molecular mechanisms involved in inflammation regulation, particularly in ENT organ tissues, where recurrent inflammation can lead to chronic conditions such as otitis media or sinusitis. Furthermore, this review compares PBM to competing methods for reprogramming macrophages and treating inflammation, highlighting its advantages of minimal toxicity, simplicity, and precision in controlling ENT immune responses.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ecology and Evolutionary Biology, University of California, Los Angeles, Los Angeles, CA, USA.
- Department of Otorhinolaryngology-Head and Neck Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
- Beckman Laser Institute, Cheonan, Korea.
- Department of Otorhinolaryngology-Head and Neck Surgery, Dankook University College of Medicine, Cheonan, Korea.
Förderung
- Dankook Institute of Medicine & Optics
- National Research Foundation of Korea
- Ministry of Education
- Korea Medical Device Development Fund
- Ministry of Science and ICT
- Ministry of Trade, Industry and Energy
- Ministry of Health and Welfare
- Ministry of Food and Drug Safety
Zitieren
APA
Woo, K., Kim, Y. S., Abueva, C., & Woo, S. H. (2025). Reprogramming Macrophage Phenotypes With Photobiomodulation for Improved Inflammation Control in ENT Organ Tissues. Clinical and Experimental Otorhinolaryngology, 18(1), 1-13. https://doi.org/10.21053/ceo.2024.00286
Vancouver
Woo K, Kim YS, Abueva C, Woo SH. Reprogramming Macrophage Phenotypes With Photobiomodulation for Improved Inflammation Control in ENT Organ Tissues. Clinical and Experimental Otorhinolaryngology. 2025;18(1):1-13. doi:10.21053/ceo.2024.00286
BibTeX
@article{Woo2025,
author = {Woo, Ken and Kim, Yeon Soo and Abueva, Celine and Woo, Seung Hoon},
title = {Reprogramming Macrophage Phenotypes With Photobiomodulation for Improved Inflammation Control in ENT Organ Tissues},
journal = {Clinical and Experimental Otorhinolaryngology},
year = {2025},
volume = {18},
number = {1},
pages = {1--13},
doi = {10.21053/ceo.2024.00286}
}
EUVIMED